Esperion Therapeutics Free Cash Flow Insights

Esperion Therapeutics, Inc. (ESPR)

2.025 -0.02 (-1.22%) USD | NASDAQ | Apr 17, 15:09

View Free Cash Flow for ESPR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Free Cash Flow Chart

Start Trial

View Historical Data

Start Trial

View Free Cash Flow Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Free Cash Flow Benchmarks

Start Trial

Nektar Therapeutics	-208.68M
Harrow, Inc.	42.76M
Corcept Therapeutics, Inc.	141.78M
Catalyst Pharmaceuticals, Inc.	208.61M
Regeneron Pharmaceuticals, Inc.	3.765B

Cash from Operations (Quarterly)	45.24M
Cash from Financing (Quarterly)	30.16M
Free Cash Flow Per Share (Quarterly)	0.159
Free Cash Flow to Equity (Quarterly)	98.23M
Free Cash Flow to Firm (Quarterly)	67.22M
Free Cash Flow Yield	-2.94%